Luca Gattinoni

22PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Life historiesElectrical machines and drivesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity.

Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola

|Feb 24, 2026
Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory.

Sina Frischholz, Ev-Marie Schuster, Myriam Grotz

|Oct 09, 2025
Targeting organelle function in T cells for cancer immunotherapy.

Jeremy G Baldwin, Christoph Heuser-Loy, Luca Gattinoni

|Aug 28, 2024
NaCl enhances CD8+ T cell effector functions in cancer immunotherapy.

Caterina Scirgolea, Rosa Sottile, Marco De Luca

|Aug 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.

Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi

|Aug 08, 2024
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling.

Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni

Pageof 4